Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development.
<h4>Background</h4>COPD is a pulmonary disorder often accompanied by cardiovascular disease (CVD), and current treatment of this comorbidity is suboptimal. Systemic inflammation in COPD triggered by smoke and microbial exposure is suggested to link COPD and CVD. Mesenchymal stromal cells...
Saved in:
| Main Authors: | P Padmini S J Khedoe, Stan de Kleijn, Annemarie M van Oeveren-Rietdijk, Jaap J Plomp, Hetty C de Boer, Melissa van Pel, Patrick C N Rensen, Jimmy F P Berbée, Pieter S Hiemstra |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183741&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obstacles in Haemocompatibility Testing
by: W. van Oeveren
Published: (2013-01-01) -
Response of Human Mesenchymal Stromal Cells from Periodontal Tissue to LPS Depends on the Purity but Not on the LPS Source
by: Christian Behm, et al.
Published: (2020-01-01) -
Pulmonary Emphysema and Intracranial Aneurysms in Smokers With Hypertension
by: Pim A. de Jong, et al.
Published: (2025-01-01) -
Differentiating Emphysema From Emphysema-Dominated COPD Patients with CT Imaging Feature and Machine Learning
by: Guo W, et al.
Published: (2025-07-01) -
Subcutaneous Emphysema and Pneumomediastinum after Tonsillectomy
by: George Koukoutsis, et al.
Published: (2013-01-01)